What Does Wolverine (BPC-157 + TB-500) Dissolve In? Solvents Explained
Solubility behaviour is where compounds in this library differ most sharply from one another. For Wolverine (BPC-157 + TB-500), the determining factors are structural: two-component repair blend — bpc-157 (5 mg) + tb-500 (5 mg) in one 10 mg vial.
Overview
Both parts are water-friendly and dissolve together in plain bacteriostatic water.
What Wolverine (BPC-157 + TB-500) actually is
One vial holding the two most-studied repair peptides together: BPC-157 (5 mg) and TB-500 (5 mg) in one 10 mg vial. BPC-157 is studied around blood-vessel formation and gut and tendon repair; TB-500 around cell movement and wound healing. Two complementary repair routes in one set.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested for HPLC purity and content, ≥99% purity, with a Certificate of Analysis available on request. Ships across Canada.
Technical detail below
How Wolverine (BPC-157 + TB-500) behaves in solution
Both components are freely water-soluble and dissolve together in plain bacteriostatic water without acidification. Add diluent gently, since TB-500 is a light powder that can scatter.
Commonly reconstituted so the combined solids sit around 5 mg/mL.
Suitable solvents, in order
Structural basis
Wolverine (BPC-157 + TB-500) is two-component repair blend — bpc-157 (5 mg) + tb-500 (5 mg) in one 10 mg vial. Wolverine combines the two most-studied tissue-repair peptides in a single 10 mg vial: BPC-157 (5 mg) and TB-500 (5 mg). It inherits the handling profile of both — the forgiving, gastric-derived BPC-157 and the oxidation-sensitive Thymosin-Beta-4 fragment TB-500 — so the blend is handled to the stricter of the two.
What Wolverine (BPC-157 + TB-500) is studied for
BPC-157 is studied around angiogenesis and growth-factor signalling; TB-500 around actin-mediated cell migration — non-overlapping routes into tissue repair.
Studied together in connective-tissue and wound-healing research designs where both mechanisms are of interest.
Because their mechanisms do not overlap, the two are frequently examined in parallel rather than as substitutes for one another.
Summarizes published preclinical literature — see the selected references below. Provided for research reference only; not a claim of efficacy or a description of human use.
References describe in-vitro and preclinical research and are listed for reference only — not evidence of efficacy and not a description of human use.
More Wolverine (BPC-157 + TB-500) reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Solubility reference for other compounds
Reviewed for research-use compliance by Kobi Williams, Founder — Popular Peptides Canada. Last reviewed 22 July 2026.
Wolverine (BPC-157 + TB-500) is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.